Andrew D. Rhim

10.0k total citations · 3 hit papers
68 papers, 6.5k citations indexed

About

Andrew D. Rhim is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Andrew D. Rhim has authored 68 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 25 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Andrew D. Rhim's work include Pancreatic and Hepatic Oncology Research (33 papers), Cancer Cells and Metastasis (17 papers) and Cancer Genomics and Diagnostics (9 papers). Andrew D. Rhim is often cited by papers focused on Pancreatic and Hepatic Oncology Research (33 papers), Cancer Cells and Metastasis (17 papers) and Cancer Genomics and Diagnostics (9 papers). Andrew D. Rhim collaborates with scholars based in United States, Canada and Germany. Andrew D. Rhim's co-authors include Ben Z. Stanger, Gregory L. Beatty, Robert H. Vonderheide, Emily T. Mirek, Anil K. Rustgi, Maximilian Reichert, Nicole M. Aiello, Anirban Maitra, Florencia McAllister and Jennifer M. Bailey and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Andrew D. Rhim

67 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EMT and Dissemination Precede Pancreatic Tumor Formation

2012 1.6k citations Andrew D. Rhim, Emily T. Mirek et al. profile →
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

2014 1.5k citations Andrew D. Rhim, Paul E. Oberstein et al. Cancer Cell profile →
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer

2012 727 citations Andrew D. Rhim, Ben Z. Stanger et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew D. Rhim United States	29	4.5k	2.4k	1.6k	1.5k	823	68	6.5k
Mert Erkan Germany	42	3.7k 0.8×	1.8k 0.8×	1.1k 0.7×	943 0.6×	1.6k 2.0×	85	5.8k
Shicheng Su China	29	2.4k 0.5×	3.1k 1.3×	2.2k 1.4×	2.5k 1.6×	272 0.3×	53	6.3k
Swarnali Acharyya United States	21	1.9k 0.4×	3.2k 1.4×	1.2k 0.8×	787 0.5×	259 0.3×	32	5.6k
Desmond G. Powe United Kingdom	36	2.6k 0.6×	1.5k 0.6×	1.8k 1.1×	878 0.6×	374 0.5×	63	5.2k
Marina Pasca di Magliano United States	40	4.7k 1.0×	5.0k 2.1×	1.5k 1.0×	1.8k 1.2×	1.0k 1.2×	114	8.5k
Fengxi Su China	29	2.2k 0.5×	2.3k 1.0×	1.7k 1.1×	1.5k 1.0×	259 0.3×	55	4.6k
Hiroshi Kijima Japan	39	2.5k 0.6×	3.1k 1.3×	1.5k 0.9×	756 0.5×	1.1k 1.3×	286	6.4k
Robert R. Langley United States	37	1.9k 0.4×	2.0k 0.9×	908 0.6×	664 0.4×	233 0.3×	66	4.5k
Sandra S. McAllister United States	24	2.8k 0.6×	2.3k 1.0×	1.2k 0.7×	1.1k 0.8×	185 0.2×	46	5.1k
Maarten F. Bijlsma Netherlands	35	1.9k 0.4×	2.2k 0.9×	915 0.6×	486 0.3×	636 0.8×	135	4.7k

Countries citing papers authored by Andrew D. Rhim

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Rhim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Rhim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Rhim more than expected).

Fields of papers citing papers by Andrew D. Rhim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Rhim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Rhim. The network helps show where Andrew D. Rhim may publish in the future.

Co-authorship network of co-authors of Andrew D. Rhim

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Rhim. A scholar is included among the top collaborators of Andrew D. Rhim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Rhim. Andrew D. Rhim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thege, Fredrik I., et al.. (2022). A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma. Cancer Research. 82(15). 2761–2776. 16 indexed citations

Thege, Fredrik I., Vidhi Chandra, Robert W. Cowan, et al.. (2022). Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling. Development. 150(2). 2 indexed citations

Zaid, Mohamed, Baishali Chaudhury, J. Zhang, et al.. (2020). Pancreatic Ductal Adenocarcinoma Immune and Stromal Elements Differ in Spatial Distribution Based on Response to Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 108(3). e606–e606. 1 indexed citations

Goel, Neha, Andrew D. Rhim, Beth Schrope, et al.. (2020). Is It Time To Move Beyond Fear Of Cell Salvage And Misconceptions About Metastasis: Evaluating The Feasibility Of Autologous Blood Transfusion For Patients With Pancreatic Ductal Adenocarcinoma. HPB. 22. S11–S12. 1 indexed citations

Vicente, Diego, Andrew Lee, Carolyn Hall, et al.. (2019). Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. Journal of Surgical Research. 243. 90–99. 10 indexed citations

Brown, Justin C., Andrew D. Rhim, Sara L. Manning, et al.. (2018). Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer. PLoS ONE. 13(10). e0204875–e0204875. 34 indexed citations

Meyer, Kevin A., Christopher K. Neeley, Nicki A. Baker, et al.. (2016). Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer. Biochemistry and Biophysics Reports. 7. 144–149. 56 indexed citations

Rhim, Andrew D., Martin Jechlinger, & Anil K. Rustgi. (2015). Culturing Mouse Tumor Cells. Cold Spring Harbor Protocols. 2015(6). pdb.top069989–pdb.top069989. 1 indexed citations

Rhim, Andrew D.. (2015). Creation of Primary Cell Lines from Lineage-Labeled Mouse Models of Cancer. Cold Spring Harbor Protocols. 2015(5). pdb.prot078287–pdb.prot078287. 3 indexed citations

10.

Normolle, Daniel P., Douglas J. Hartman, Haoqiang Ying, et al.. (2014). Neuroplastic Changes Occur Early in the Development of Pancreatic Ductal Adenocarcinoma. Cancer Research. 74(6). 1718–1727. 143 indexed citations

11.

Rhim, Andrew D., Paul E. Oberstein, Dafydd Thomas, et al.. (2014). Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma. Cancer Cell. 25(6). 735–747. 1513 indexed citations breakdown →

12.

Zhang, Yaqing, Wei Yan, Meredith A. Collins, et al.. (2013). Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance. Cancer Research. 73(20). 6359–6374. 197 indexed citations

13.

Reichert, Maximilian, Shigetsugu Takano, Johannes von Burstin, et al.. (2013). The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes & Development. 27(3). 288–300. 79 indexed citations

14.

Rhim, Andrew D.. (2013). Epithelial to mesenchymal transition and the generation of stem-like cells in pancreatic cancer. Pancreatology. 13(2). 114–117. 23 indexed citations

15.

Plentz, Ruben R., Andrew D. Rhim, Daniel L. Abravanel, et al.. (2009). Inhibition of γ-Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma. Gastroenterology. 136(5). 1741–1749.e6. 132 indexed citations

16.

Rhim, Andrew D. & Michael L. Kochman. (2008). A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?. Clinical Gastroenterology and Hepatology. 6(7). 741–745. 1 indexed citations

17.

Pazianas, Michael, et al.. (2006). The Effect of Anti‐TNF‐α Therapy on Spinal Bone Mineral Density in Patients with Crohn's Disease. Annals of the New York Academy of Sciences. 1068(1). 543–556. 52 indexed citations

18.

Campbell, Mical S., Gary R. Lichtenstein, Andrew D. Rhim, Michael Pazianas, & Thomas W. Faust. (2005). Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis. Liver International. 25(2). 311–316. 21 indexed citations

19.

Rhim, Andrew D., et al.. (2004). Altered terminal glycosylation and the pathophysiology of CF lung disease. Journal of Cystic Fibrosis. 3. 95–96. 17 indexed citations

20.

Rhim, Andrew D.. (1996). The Special Relationship Between Student-Athletes and Colleges: An Analysis of a Heightened Duty of Care for the Injuries of Student-Athletes. Marquette sports law review. 7(1). 329. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact